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Abstract
T lymphoma invasion and metastasis protein (Tiam1) is up-regulated in variety of cancers and its expression level is related
to metastatic potential of the type of cancer. Earlier, Tiam1 was shown to be overexpressed in retinoblastoma (RB) and we
hypothesized that it was involved in invasiveness of RB. This was tested by silencing Tiam1 in RB cell lines (Y79 and Weri-
Rb1) using siRNA pool, targeting different regions of Tiam1 mRNA. The cDNA microarray of Tiam1 silenced cells showed
gene regulations altered by Tiam1 were predominantly on the actin cytoskeleton interacting proteins, apoptotic initiators
and tumorogenic potential targets. The silenced phenotype resulted in decreased growth and increased apoptosis with
non-invasive characteristics. Transfection of full length and N-terminal truncated construct (C1199) clearly revealed
membrane localization of Tiam1 and not in the case of C580 construct. F-actin staining showed the interaction of Tiam1
with actin in the membrane edges that leads to ruffling, and also imparts varying invasive potential to the cell. The results
obtained from our study show for the first time that Tiam1 modulates the cell invasion, mediated by actin cytoskeleton
remodeling in RB.
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Introduction
Retinoblastoma (RB) is an intraocular tumor of childhood. As
per International Retinoblastoma Staging Working Group
(IRSWG) most of the RB tumors are found to have massive
choroidal, optic nerve, and anterior segment invasion [1]. The risk
factors include choroidal invasion .3 mm (CI.3 mm), post
laminar and surgical end of optic nerve invasion. Understanding
the molecular regulation of tumor cell invasion and apoptosis helps
in identifying new therapeutic targets.
T lymphoma invasion and metastasis protein (Tiam1) was first
identified as an invasion and metastasis inducing gene using T
lymphoma cells by proviral tagging and in vitro selection for
invasiveness [2,3]. Tiam1 is a guanine nucleotide exchange factor
(GEF) that mediates the specific activation of Rac1 [4,5,6]. Small
guanine triphosphate (GTP) binding proteins belonging to Ras
superfamily act as molecular switches for activation of cellular
activities such as signal transduction, actin cytoskeleton remodel-
ing, microtubule stabilization, centrosome reorganization and
intracellular trafficking [7,8,9,10]. Aberrations or mutations of
these proteins lead to malignancy of the cell. In response to
extracellular signals, GEFs play a major role by catalyzing the
activation of GTP-binding proteins by dissociation of guanosine
diphosphate bound to it. RhoA, Rac1 and Cdc42 are key proteins
of Rho family that depends on GEFs for their acitivation [11,12].
Tiam1 has been linked with cancer progression and having
growth promoting functions based on the tumor type. Overex-
pression of N-terminus truncated Tiam1 is found to impart
oncogenic activity in NIH 3T3 cells [13,14]. Similarly, mutations
in Tiam1 gene are able to transform NIH 3T3 cells [15].
Oncogenic potential of Tiam1 was found to be present in various
tumors with respect to the tumor grade and stage. The over
expression of Tiam1 in breast carcinoma, nasopharyngeal
carcinoma, hepatocellular carcinoma, renal cell carcinoma,
retinoblastoma, colorectal carcinoma, lung and prostate cancer
has been previously reported [16,17,18,19,20,21,22]. Tiam1 is
negatively correlated in case of renal carcinoma, where it inhibits
invasion by promoting E-cadherin mediated adhesion [15].
Tiam1 contains consensus myristoylation sequence at the amino
terminus, two PEST sequences, a Ras binding domain (RBD),
PSD-95/DlgA/ZO-1 domain (PDZ), two pleckstrin homology
(PH) domains and DH domain [23,24,25] (Figure 1A). The PH
domain present in carboxy terminal next to DH domain is similar
in all other GEFs. The DHR domain is important for the protein-
protein interaction [26]. Presence of Tiam1 on the membrane
surface is accomplished through the N-terminal PH domain, and
not by the c-terminal PH domain or DHR domain. Using
truncated constructs of Tiam1, localization of Tiam1 in the
membrane is shown to be necessary for the membrane ruffling
[24,27,28].
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Earlier, we showed the expression of Rho, Rac, Cdc42 and
Tiam1 in RB. Additional studies on E-Cadherin and N-Cadherin
has helped us to correlate the expression levels of these antigens
with respect to the function they mediate in the RB tumor
progression. Especially the expression of Tiam1 was positively
correlated with the invasive potential of the tumors [18]. The
functional relevance behind this overexpression of Tiam1 in
tumorogenesis and invasion of RB is not yet elucidated. In the
current study, we analyzed the effect of Tiam1 on cell proliferation
and invasion using RB cell lines, Y79 and Weri-Rb1. Additionally,
we addressed the effects of the truncated constructs with respect to
subcellular localization and F-actin based interaction and inva-
siveness attributed to the RB cell lines.
Materials and Methods
Cell culture
Human RB cell lines Y79 and Weri-Rb1 were obtained from
the cell bank, RIKEN BioResource Center (Ibaraki, Japan).
Roswell Park Memorial Institute (RPMI) 1640 media, Heat-
inactivated Fetal Bovine Serum (FBS), Poly-L-Lysine (PLL) were
purchased from Sigma Aldrich (St. Louis, MO). The cells were
cultured in RPMI 1640 medium, supplemented with 10% fetal
bovine serum (FBS) (Gibco, Invitrogen, India) along with 1% Pen-
strep (Hi-Media, Mumbai, India). The cells were maintained in
5% CO2 incubator at 37uC.
Sample collection and Ethics statement
Tumors samples were collected from enucleated eyeballs of RB
patients as a part of treatment with written consent from patient/
guardian and utilized for research purpose anonymously. Retina
samples were collected from normal cadaveric donor eyeballs from
C U shah eye bank, Medical Research Foundation, Sankara
Nethralaya, India. This work was approved by Vision Research
Foundation ethics committee and done at Vision Research
Foundation, Sankara Nethralaya (Ethical clearance no: 136-
2008-P).
Figure 1. Schematic representation of Tiam1 constructs and expression level of Tiam1 in RB tumors compared to normal retina.
terminal PH domain; CC: Coiled-coil region; Ex: Extended structure; RBD: Ras-binding domain; PDZ: PSD-95/DlgA/ZO-1 domain; DH: Dbl homology
domain and PHc: C-terminal PH domain. Deletion of N-terminal myr and P sites leaves the active C1199 form of Tiam1 in truncated constructs. C580
contains only DH and C-terminal PH domain. B. Fold difference in the expression of Tiam1 mRNA in RB tumors versus normal retina by qPCR analysis.
The relative fold change (log2 ratio) in Tiam1 mRNA expression is calculated by normalizing with b2-microglobulin using normal retina as control
sample. C. Western blot analysis of Tiam1 protein expression in RB tumors and normal retina shows Tiam1 at 180 kda and b-actin at 42 Kda. D.
Densitometry analysis of the Tiam1 protein expression in RB tumors vs normal retina (n = 2). RB1 to RB7 invidividual expression normalized with
averaged NR is represented.
doi:10.1371/journal.pone.0070422.g001
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  Full length Tiam1 consists of 1591 aminoacids. Tiam1 has several specific domains such as, Myr: Myristoylation site; P: PEST sequences; PHn: N-A.   
Transfection and RNA interference of Tiam1
Full-length and N-terminal truncated C1199 and C580 Tiam1
containing a hemagglutinin tag at the 39 end, cloned in the
eukaryotic expression vector pUTSV1 (Eurogentec, Belgium) were
procured from John G Collard, Netherlands Cancer Institute [13].
Tiam1 constructs were transiently transfected in Y79 and Weri-
Rb1 cell lines with LipofectAMINE 2000 (Invitrogen) as
prescribed in manufacture’s protocol. For Tiam1 silencing, three
pre-designed short interfering RNA (siRNA) sequences targeting
different regions of Tiam1 mRNA were purchased from Qiagen,
Valencia, USA. The siRNA sequences are as follows, GGCGAG-
CUUUAAGAAGAAATT (sense) and UUUCUUCUUAAAG-
CUCGCCGT (antisense) for Tiam1_1 (T1), CAUGUAGAG-
CACGAGUUUUTT (sense) and AAAACUCGUGCUCUA-
CAUGTT (antisense) for Tiam1_5 (T5), GGUUCUGUCUGCC-
CAAUAATT (sense) and UUAUUGGGCAGACAGAACCAG
(antisense) for Tiam1_6 (T6). Briefly, the cells were transfected
with 200 nM of pooled siRNA sequences by using LipofectA-
MINE 2000. Scrambled siRNA was used as a negative control in
all experiments. The cells were collected after 48 hrs for further
experiments.
Total RNA isolation and Quantitative PCR
The total mRNA was isolated from transfected cells and fresh
RB tumors by RNAeasy kit (Qiagen, Valencia, USA) and Trizol
respectively. 1 mg of total RNA was transcribed into cDNA using
Figure 2. Knockdown of Tiam1 in Y79 and Weri-Rb1 cell lines using RNA interference. A. Tiam1 silencing in Y79 cells using three siRNA
sequences (T1, T5 & T6) targeting different regions of the mRNA at 50 nM and 100 nM concentrations. B. Down-regulation of Tiam1 in Y79 and Weri-
Rb1 cells compared to scrambled siRNA mediated by transfection of 100 nM and 200 nM of pooled siRNA. The statistical analysis was calculated
using students unpaired t-test and p,0.05 is indicated as asterisk. C. Western blot analysis of Tiam1 post silencing in Y79 and Weri-Rb1 cell lines. b-
actin showing a band at 42 KDa is used to normalize within sample and between siRNA transfected and untransfected cells, on the right is the
densitometry analysis of western blot showing the relative band intensity of Tiam1 expression of siRNA transfected cells compared to scrambled
siRNA transfected cells. The statistical analysis was calculated using students unpaired t-test and p,0.05 is indicated as asterisk. D.
Immunofluorescence images of Tiam1 silenced Y79 and Weri-Rb1 cells showing the reduction of Tiam1 expression on plasma membrane compared
to untransfected cells showing high level of Tiam1 expression on plasma membrane. The images were taken at ten fields under 100X oil immersion
objective. Scale bar: 20 mm. Tiam1 is shown as green and nucleus counterstained with DAPI fluoresces blue in color.
doi:10.1371/journal.pone.0070422.g002
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oligo-dT and random hexamers. The quantitative PCR was
performed in Applied Biosystem 7500 by using Sybr-green
(Thermoscientific, Mumbai, India). The primer sequences for
Tiam1, 18S and b2M were as follows, FP: 59AAGACGTACT-
CAGGCCATGTCC-39and RP: 59-GACCCAAATGTCG-
CAGTCAG-39 for Tiam1, FP: 59- AACCCGTTGAACCC-
CATT-39 and RP: 59-CCATCCAATCGGTAGTAG-39 for 18S,
and FP: 59-TATCCAGCGTACTCCAAAGA-39 and RP: 59-
GACAAGTCTGAATGCTCCAC –39 for b2M. Comparative
quantification (normal retina vs primary RB tumors or untreated
cells vs Tiam1 siRNA treated cells) was determined using the
formula 22DDCt and relative expression values normalized to the
18S or b2M endogenous control were used for plotting.
Experiments were performed in triplicate for the same samples.
Western Blotting
Transfected cells and RB tumors were collected and washed
with 1X PBS followed by cell lysis in RIPA buffer (containing
50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM PMSF, 1 mM
EDTA, 1%Triton X-100, 1% Sodium deoxycholate, 0.1% SDS
and Protease inhibitor cocktail, Sigma). 50–100 mg of protein
lysate was resolved on 8% SDS Polyacrylamide gel and then
electroblotted onto nitrocellulose membrane at 100V for 90 min.
The membrane was blocked in 5% skimmed milk, further
incubated with primary anti-Tiam1 polyclonal antibody (raised
in rabbit, C-16, Santacruz) in 1:100 dilutions and anti-b actin
monoclonal antibody (raised in mouse, Sigma) in 1:2000 at 4uC for
overnight. The membrane was washed thrice with TBST (1 M
Figure 3. Analysis of Apoptosis and viability of Tiam1 silenced Y79 and Weri-Rb1 cells. A. invitro cell apoptosis assay showing the
difference in mean fluorescence intensity between Tiam1 siRNA treated and Scrambled siRNA treated Y79, Weri-Rb1 cells. On the right panel, overlay
graph showing the Annexin V expression between the samples. B. MTT assay showing the significant reduction in cell viability in Tiam1 silenced RB
cell lines. Error bar represents the standard deviation of triplicates value and the statistical analysis was calculated using students unpaired t-test and
p,0.05 is indicated as asterisk.
doi:10.1371/journal.pone.0070422.g003
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Tris-HCl pH-7.6 containing 0.1% Tween-20 and 0.8% NaCl) and
incubated with HRP-conjugated secondary antibody at 1:2500
dilution for 2 hrs. The membrane was detected by supersignal
west femto maximum sensitivity substrate (Thermoscientific,
Rockford, USA). The blots are representative of three experi-
ments.
Figure 4. cDNA microarray in Tiam1 silenced Y79 and validation of de-regulated genes in RB cell lines & tumors. A. Whole genome
microarray of Tiam1 silenced Y79 cells was performed using Human-Ht12 beadChip ver. 3 platform. Hierarchical Cluster represents the expression
profile of de-regulated genes upon Tiam1 silencing in Y79 cells, compared to untransfected cells. B. Real-time PCR results showing the mRNA
expression of selected genes from microarray analysis in Tiam1 silenced Y79 and Weri-Rb1 cells C. Relative fold change in the mRNA expression of
selected panel of genes verified in primary retinoblastoma showing the negative correlation to that of Tiam1 silenced Y79 and Weri-Rb1
retinoblastoma cells. Error bar represents the standard deviation of triplicates value.
doi:10.1371/journal.pone.0070422.g004
Table 1. Primer sequences for the selected panel of validated genes.
GENE PRIMER SEQUENCES
RAP2A FP: AGA TCA TCC GCG TGA AGC RP: CCC CAC TCT TCA GCA AGG
BAX FP: TGG AGCTGCAGAGGATGATTG RP: GAAGTTGCCGTCAGAAAACATG
Rabl3 FP: TTGGGAGACTCAGGTGTTGGGAAA RP: CAGTTGGCACCAAATCCCTGTTGA
PAK2 FP: GAATGGAAGGATCTGTTAAGCTCACT RP: GCCATAAGCTTTCCGTGTAACC
MAP1B FP: AAAGTGTCCAGGGTGGCTTC RP: CTCCTGGTACCATTCCCTCA
TRAF6 FP: TGGCATTACGAGAAGCAGTG RP: GTTCCATCTTGTGCAAACAACC
DFFB FP: GGCCTGCTTTTTACCTCAGA RP: CGTTTCCGCACAGGCTGCTT
MLCK2 FP: GAGCTGAGGACCGGGAAT RP: AGGTACAGACTGCCCCAAAC
CALPAIN7 FP: ATCTGGAAAGAGTTCAAGCT RP: GCACGCTCTAAGACCAACAG
PDCD7 FP: TTGACCCAGGCTGCCTAT RP: AATCTCCTGCTCGCGTTC
MYOT FP: CGACTGCAAGTTCCTACATCAC RP: TGAATGAAACGTGGTGGGTA
GAB1 FP: ACCTCAAGCCAGACAGAAAAGT RP: TCGAGCAAAACTCCTAGTGATG
doi:10.1371/journal.pone.0070422.t001
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Immunofluorescence
For immunofluorescence, cells were seeded on Poly-L-Lysine
coated cover slips in 24-well plate. After 48 hrs of transfection,
cells were fixed with 4% paraformaldehyde, permeabilized with
0.1% Triton X-100 and blocked with 5% BSA in PBS for 30 mins.
The cells were incubated with polyclonal anti-Tiam1 antibody
(1:25) for overnight at 4uC. After PBS wash cells were incubated
with FITC conjugated anti-rabbit secondary antibody (1:500) for
Figure 5. F-actin staining and invasion of Tiam1 deficient RB cell lines. A. Tiam1 silenced Y79 cells and Weri-Rb1 cells were fixed,
immunofluorescently labeled for Tiam1, nucleus stained with DAPI, stained with phalloidin and images were taken at 40X in ten fields. Bar represents
20 mm. B. Phase contrast microscope images of wound healing assay showing the cell migration pattern in Tiam1 deficient retinoblastoma cell lines
at 0 hr and 48 hrs post silencing. Tiam1 knockdown cells were unable to migrate whereas the untransfected and control cells showed increased
migration, migrated cells were indicated with arrows. The images were acquired using AxioObserver microscope at 56objective with 16optovar.
doi:10.1371/journal.pone.0070422.g005
Figure 6. Matrigel invasion assay of Tiam1 deficient RB cell lines. A. Y79 panel showing the invasion of untransfected, siTiam1 treated and
scrambled siRNA treated cells. B.Weri-Rb1 cells. The matrigel invasion chambers post invasion was stained with crystal violet and images acquired at
206objective. The experimental results were representative of triplicate result repeated twice.
doi:10.1371/journal.pone.0070422.g006
Tiam1 Promotes Invasion of Retinoblastoma
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2 hrs at room temperature then incubated with TRITC conju-
gated phalloidin at 1:300 dilution (Sigma Aldrich, St. Louis, MO)
for 30 min whereas DAPI was used as a nuclear stain. The cover
slips were mounted and viewed under Axio Observer fluorescence
microscope (Zeiss, Germany).
Flow cytometry analysis of apoptosis
For the apoptosis assay, Annexin V kit from BD biosciences(-
San Diego, CA) was used. Briefly, cells were washed with ice
cold 1X PBS twice and resuspended in 1X binding buffer and
incubated with annexin V-FITC and Propidium iodide for
15 mins, followed by flow cytometry. Experiments were per-
formed thrice individually.
Figure 7. Localization of Full length Tiam1, C1199 Tiam1 and C580 Tiam1 in RB cell line. Immunofluorescent images of Y79 cells, B)
Weri-Rb1 cells transfected with Full length Tiam1, C1199 Tiam1 and C580 Tiam1 plasmids tagged with HA. Tiam1 and F-actin were stained as
mentioned in the materials and methods. Full length Tiam1 and C1199 Tiam1 but not C580 Tiam1 were localized to plasma membrane. Unlike Full
length Tiam1 and C1199 Tiam1, C580 Tiam1 could not induce membrane ruffling. Representative images were taken from 10 independent fields
using AxioObserver fluorescent microscope at 1006 and arrows indicate the membrane ruffling. Scale bar: 20 mm.
doi:10.1371/journal.pone.0070422.g007
Tiam1 Promotes Invasion of Retinoblastoma
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A)
Cell proliferation assay
3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) assay was performed to evaluate the percentage viability of
silenced cells. Transfected cells were incubated with 100 ml of
media containing 10 ml of MTT (5 mg/ml) and incubated for
4 hrs at 37uC. Then media with MTT was removed and 100 ml of
DMSO was added to each well the absorbance was measured at
570 nm. All experiments were performed in triplicate.
cDNA microarray
Whole genome microarray was performed in Tiam1 siRNA
treated Y79 cells along with untransfected Y79 cells. The
experiment was performed in triplicates. In brief, 500 ng of total
RNA was used for cDNA synthesis, followed by amplification/
labeling using TotalPrep RNA Amplification kit (Ambion Inc.,
Austin, TX) to synthesize biotin-labeled cRNA. The concentration
of cRNA was measured by spectrophotometer (Nanodrop, ND-
1000, Thermo scientific). Labeled, amplified cRNA (750 ng per
array) was hybridized to a ver. 3 of the Illumina Human-Ht-12
BeadChip (48 K) according to the Manufacturer’s instructions
(Illumina, Inc., San Diego, CA). The whole 48803 probes on the
Human-Ht12 beadChip ver. 3 were used and the arrays were
scanned with an Illumina Bead array Reader confocal scanner
(BeadStation 500GXDW; Illumina, Inc.). Sample Gene Profile
option of Illumina BeadStudio software was used to export the
gene expression data.
Wound healing assay
The cells were grown on PLL coated culture plate until
confluent in 1% serum medium. A wound was made by scratching
a straight line using a 200 ml pipette tip. The cells were then
washed twice, transfected and incubated further for 48 hrs with
10% FBS containing media. Images were taken under Phase
contrast microscope at 0 hr and 48 hr using AxioObserver
fluorescent microscope.
Figure 8. N-terminal PH domain maintains cell motility in retinoblastoma cells. Phase contrast images showing the migration of Y79 and
Weri-Rb1 cells transfected with Full length Tiam1, C1199 Tiam1 and C580 Tiam1 in wound-healing assay. White line indicates the original wound
edge which made by a pipette tip. The images were taken from 10 different locations. Cells transfected with full length and C1199 Tiam1 showing
significant increase in cell migration rate compared to the cells transfected with C580 Tiam1. The Images were captured at 56 objective in
AxioObserver microscope.
doi:10.1371/journal.pone.0070422.g008
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Matrigel invasion assay
Y79 and Weri-Rb1 cells were counted 24 hr post transfection of
the siTiam1 and scramble siRNA and 56104 cells in serum free
media were seeeded respectively in the rehydraded matrigel
invasion chamber with 10% FBS containing media added as
chemoattractant. Cells were allowed to incubate for 48 hr.
Chambers were removed, washed twice with 16 PBS, cleaned
the matrigel using cotton plug, fixed cells in methanol, stained with
cystal violet. The membranes were cut, removed and mounted
with DPX mountant and viewed under 206 objective of Axio-
Observer microscope.
Statistical analysis
Statistical analysis was performed by unpaired students t-test
using Graphpad software on the triplicate data generated from
three individual experiments. The two-tailed P values less than
0.05 were considered as significant.
Results
Differential expression of Tiam1 in RB tumors
In our earlier study, we reported the expression of Tiam1
protein in RB tumors by immunohistochemistry. In this study, we
analyzed both the mRNA and protein levels of Tiam1 through
qPCR and western blotting. The differential expression of Tiam1
in RB tumors (tumors with choroid invasion (CI) ,3 mm and
CI.3 mm), Y79 and Weri-Rb1 cell lines were compared to
normal cadaveric human retina (n = 2). On average of 7.5661.8,
3.360.3 and 5.360.5 fold were expressed higher in RB tumors,
Y79 and Weri-Rb1 respectively (Figure 1B) using b-2 micro-
globulin for normalization in relative quantitative PCR. Tiam1
protein levels were higher in expression compared to the normal
retina on Western blot. Tiam1 protein bands were observed at
,180 KDa, a loading control b-actin was detected at ,42 KDa
in Western blot (Figure 1C). The protein bands intensity were
represented as graph in Figure 1D.
RNA interference of Tiam1 in RB cell lines
To study the cellular events mediated by Tiam1 in RB, Tiam1
knockdown is performed transiently in Y79 cells with three
different siRNA sequences (T1, T5 and T6) as mentioned in
methods. After 48 h of transfection, the silencing efficiency of each
siRNA duplexes was determined by Real-time PCR (Figure 2A).
Individual siRNA duplexes did not show significant down-
regulation of Tiam1 in Y79. As per Parsons et al. (2009) the
silencing efficiency was increased when all the three siRNA
sequences were pooled and transfected [29]. 200 nM of siRNA
pools showed –2.75 and 22.0 fold down regulation in Y79 and
Weri-Rb1 respectively (Figure 2B). This was further confirmed at
protein level by Western blotting (Figure 2C). The intensity of
protein bands were measured using ImageJ software and
percentage of Tiam1 expression upon siRNA treatment was
calculated and represented as graph. In general, Tiam1 is localized
in both plasma membrane and cytoplasm of untransfected cells
but the expression level on plasma membrane was drastically
reduced upon Tiam1 silencing in Y79 and Weri-Rb1 cells
(Figure 2D).
Figure 9. Tiam1mediated signaling pathway. Schematic representation showing the upstream and downstream effects of Tiam1 in intracellular
pathways. External stimulants phosphorylate the receptor tyrosine kinase which inturn activates Ras-GTP, binds to RBD domain of Tiam1. Interaction
of EphB, CD44 and Ankyrin Proteins with PHn domain of Tiam1 and CADM1 with PDZ domain leads to the activation of Rac-GTP at DH domain of
Tiam1. The activated Rac-GTP involves in various signaling pathways, mainly on actin cytoskeleton. The binding of PHn domain to phosphoinositide
facilitates the membrane localization of Tiam1. PDGF: Platelet-derived growth factor; EGF: Epidermal growth factor; RTK: Receptor tyrosine kinase;
PIP3: Phosphatidyl inositol triphosphate; PIP2: Phosphatidyl inositol diphosphate; PHn: N-terminal PH domain; RBD: Ras binding domain; PDZ: PSD-
95/DglA/ZO-1 domain; DH: Dgl homology domain; PHc: C-terminal PH domain; JNK: Jun N-terminal kinase; PAK: p21-activated kinase.
doi:10.1371/journal.pone.0070422.g009
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Tiam1 regulates apoptosis and viability in RB cells
Further to understand the functional relevance behind the
expression of Tiam1 in cellular activities such as apoptosis and
viability, studies were carried out in RB cell lines, Y79 and Weri-
Rb1 in the presence and absence of Tiam1. To elucidate apoptotic
effects upon silencing of Tiam1 Annexin-V assay was performed.
Results showed 15% and 50% of late apoptotic cells in Y79 and
Weri-Rb1 cells respectively upon siTiam1 (Figure 3A). Upon
silencing with Tiam1, the cellular metabolic activity of Y79 and
Weri Rb1 decreased by 25% in MTT assay (Figure 3B).
siRNA mediated Tiam1 silencing results in de-regulation
of gene expression in Y79 cells
cDNA microarray was performed to analyze the genes
regulated upon Tiam1 knock down using Y79 RB cell line. Raw
data files were normalized using GeneSpring GX v 12.0. A total of
790 transcripts were observed to be differentially expressed in
Tiam1 silenced cells above 1.0 fold (p,0.05) of which 302 genes
were up-regulated and 488 genes were down-regulated. Hierar-
chical clustering of differentially regulated genes was done using
Pearson uncentered distance matrix and average linkage rule to
establish gene clusters that differentiate the two groups of samples
(Figure 4A). Biological analysis of differentially expressed genes
was done for Gene Ontology and Pathways using DAVID tool
(http://david.abcc.ncifcrf.gov/). Statistically significant ontologies
and pathways were filtered based on p-Value ,0.05 (Obtained
using Fischer Exact Test) with Benjamini Hocheberg FDR
correction (Figure S1). The data obtained from microarray
analysis was deposited in NCBI’s Gene Expression Omnibus
(GEO45130) as per MIAME guidelines. The significantly de-
regulated genes in response to Tiam1 silencing are listed in
Table S1.
Significantly down-regulated genes in Tiam1 silenced
Y79 cells
Since Tiam1 acts as GEF, silencing of Tiam1 led to down-
regulation of most of the RAS (rat sarcoma) oncogene family of
small GTPases such as RAB8B, RAP2A, RHOT2, RAB3D,
RAB14, RAB40B, and RABL3, actin cytoskeleton genes- Homo
sapiens p21 (CDKN1A)-activated kinase 2 (PAK2), Homo sapiens
CDC42 binding protein kinase gamma (CDC42BPG), Homo
sapiens CD2-associated protein (CD2AP), Homo sapiens fibroblast
growth factor 16 (FGF16), Homo sapiens actin-like protein
(FKSG30), Homo sapiens microtubule-associated protein 1B
(MAP1B)., focal adhesion genes- Homo sapiens tubulin, delta 1
(TUBD1), Homo sapiens chondroadherin (CHAD), Homo sapiens
myotilin (MYOT), Homo sapiens myosin light chain kinase 2
(MYLK2), Homo sapiens PDGFA associated protein 1 (PDAP1),
Homo sapiens C-terminal binding protein 2 (CTBP2), Homo sapiens
CREB regulated transcription coactivator 1 (CRTC1), Homo
sapiens matrix metallopeptidase 27 (MMP27), Homo sapiens matrix
metallopeptidase 28 (MMP28), Homo sapiens GRB2-associated
binding protein 1 (GAB1), Homo sapiens calpain 7 (CAPN7).
Significantly up-regulated genes in Tiam1 silenced Y79
cells
Tiam1 knock down in Y79 cells resulted in up-regulation of
apoptotic genes- Homo sapiens BCL2-associated X protein (BAX),
Homo sapiens programmed cell death 7 (PDCD7), Homo sapiens
DNA fragmentation factor (DFFB), Homo sapiens TNF receptor-
associated factor 6 (TRAF6), Homo sapiens BCL2-like 12
(BCL2L12), GTP binding genes- Homo sapiens Rho family GTPase
2 (RND2), Homo sapiens RAS guanyl releasing protein 2
(RASGRP2), (multiple drug resistance genes) Homo sapiens ATP-
binding cassette, sub-family G member 4 (ABCG4), Homo sapiens
ATP-binding cassette, sub-family D member 1 (ABCD1), Homo
sapiens cAMP responsive element binding protein 1 (CREB1), and
Homo sapiens mitogen-activated protein kinase kinase kinase 4
(MAP3K4), Homo sapiens collagen, type VII, alpha 1 (COL7A1),
Homo sapiens suppression of tumorigenicity 5 (ST5), Homo sapiens
suppression of tumorigenicity 7 (ST7), Homo sapiens tumor protein
p63 regulated 1-like (TPRG1L), Homo sapiens claudin 6 (CLDN6),
Homo sapiens cadherin 15 (CDH15).
Validation of de-regulated genes by qPCR in Tiam1
silenced RB cell lines and primary RB tumors
From the de-regulated genes list, a panel of genes namely
PAK2, MAP1B, RABL3, RAP2A, GAB1, MLCK2, MYOT,
CALPAIN7, BAX, PDCD, TRAF6, DFFB were selected for the
confirmation of microarray analysis by quantitative PCR in Tiam1
silenced Y79 and Weri-Rb1 cells (Figure 4B). The list of primer
sequences used for the SYBR-green based qPCR is given in
Table 1. Genes involved in actin cytoskeleton were down-
regulated where as apoptotic genes were up-regulated in post
Tiam1 silenced Y79 and Weri-Rb1 cells. The mRNA expressions
of these genes in both RB cell lines were consistent with
microarray analysis. Similarly qRT-PCR was done to evaluate
the correlation of the validated genes expression in primary RB
tumors (Figure 4C). mRNA expression of these selected genes were
negatively correlate with primary RB tumors. The average fold
expression of 12 genes in 12 tumors normalized to two normal
retina were, PAK2 (5.78), MAP1B (2.88), RABL3 (5.00), RAP2A
(3.99), GAB1 (4.10), MLCK2 (3.47), MYOT (4.15), CALPAIN7
(3.17), BAX (22.25), TRAF6 (22.53), PDCD7 (22.60), DFFB
(23.00). The list of the primary tumors used and its clinic-
pathological descriptions, showing the expression levels of
validated genes are given in Table 2. Tumors with CI,3 mm
showed lesser extent of changes in gene expression compared to
tumors with CI.3 mm (tumor 2, 3, 5, 6, 7). qPCR results were
shown in Figure 4 & CI status were shown in Table 2. The
expression levels of Tiam1 is also directly correlating to the
changes in gene expression of validated targets in RB tumor.
Tiam1 regulates actin polymerization, cell migration and
invasion in RB cell lines
To investigate the involvement of Tiam1 in actin cytoskeleton
regulation, F-actin staining was performed using phalloidin in
Tiam1 silenced Y79 and Weri-Rb1 cells (Figure 5A). As
mentioned above, Tiam1 was co-localized with actin at cell
junctions. In case of Tiam1 knockdown, the cells exhibited lesser
extent of actin polymerization at the cellular junctions and actin
co-localization. Thus the results show that Tiam1 is essential for
actin re-organisation in RB cells. Additionally, the function of
Tiam1 in cell migration was assessed by wound healing assay
(Figure 5B). Tiam1 silenced RB cell lines showed impairment of
cell migration, compared to untransfected and scrambled siRNA
transfected RB cells. Silencing of Tiam1 in Weri-Rb1 had resulted
in lesser number of cells invaded across the matrigel coated
invasion chamber. This indicated the decrease in invasion
potential depends on Tiam1 expression as it is not observed in
the scramble siRNA transfected cells (Figure 6).
Plasma membrane localization of Tiam1 is mediated by
N-terminal PH domain
Since Tiam1 localizes along with F-actin and controls the actin
cytoskeleton, we investigated which domain of the protein
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regulates the localization Tiam1 on plasma membrane in RB. RB
cell lines (Y79 and Weri-Rb1) transfected with full length and
C1199 Tiam1 showed the membrane localization and induced the
membrane ruffling (Figure 7). In contrast, C580 Tiam1 was
localized to the nucleus and failed to induce membrane ruffling.
N-terminal PH domain regulates retinoblastoma cell
motility
We observed that N-terminal PH domain, but not C-terminal
PH domain modulates the localization of Tiam1 and induces
membrane ruffling in RB cells. Further we determined the
association of membrane localization of Tiam1 and cell migration
in Y79, Weri-Rb1 cells. To elucidate this, wound healing assay
was performed in Y79 and Weri-Rb1 cells. The cells transfected
with full length Tiam1 and C1199 Tiam1 were showing more cell
migration towards the wound, whereas C580 Tiam1 transfected
cells showed delayed cell migration into the wound in both cell
lines (Figure 8).
Discussion
Though Tiam1 has been shown to play a crucial role in actin
cytoskeleton, cell migration and invasion, various intracellular
pathways are involved in activation of upstream and downstream
signaling of Tiam1 (Figure 9) [9,10,13,27]. In particular, Tiam1 is
required for activation of Rac1 and cdc42 to produce specific actin
rich structures like membrane ruffling, lamellipodia, filopodia
[30,31,32,33,34,35] and for neurite outgrowth [36]. Addition to
that, Tiam1 interacts with CADM1, Ephrin and Arp2/3 to initiate
Rac1 mediated actin cytoskeleton remodeling [37,38,39]. Hence
in the current study, we analysed the importance of Tiam1 in RB
cells using short interfering RNA (siRNA) mediated knockdown
studies.
Silencing of Tiam1 in RB cell lines followed by cDNA
microarray showed various pathways and genes altered, predom-
inantly genes related to MAPK pathway, small GTPase, apoptosis
and cell migration. The impairment of cell migration in Tiam1
silenced Y79 and Weri-Rb1 cells was proved by Wound healing
and matrigel invasion assay. This correlates with the microarray
analysis where the actin cytoskeleton genes were down-regulated
in Tiam1 silenced Y79 cells resulting in lesser cellular migration
potential (Figure 5). One of the down-regulated actin cytoskeleton
gene in our microarray analysis is MAP1B (Microtubule-associat-
ed protein 1B) which is needed for axonal development, reported
to be involved in neurite growth, neuron migration and metastasis
[40,41,42]. MAP1B is found to interact with Tiam1 thereby
activating Rac1 and cdc42 and further inhibiting RhoA activity
which leads to actin polymerization and axonal elongation
[43,44]. MAP1B deficient cells exhibit a decreased cell migration
and axonal development [45,46]. The other mechanism might be
PAK mediated activation of MyosinII, a protein involved in stress
fiber formation and contraction [47]. The phosphorylation of
myosinII light chain (MLC) by myosinII light chain kinase
(MLCK) regulates actin-myosin II interaction [48]. We observed
that PAK2 and MLCK were down-regulated in Tiam1 silenced
retinoblastoma Y79 cells. Moreover, small GTPase subfamily
Rab-like 3 (Rabl3) and actin-binding protein Myotilin, promote
motility, tumor cell survival [49]. The down-regulation of Rabl3
and myotilin might as well attribute to the suppression of cell
motility in Tiam1 silenced cells. The expression level of these
genes when validated in primary RB tumors showed differential
expression correlating with their CI status. CI represents the
invasion potential of the given tumor during the enucleation,
which may or may not have undergone chemotherapeutic
treatment. The tumors with CI.3 mm compared to CI,3 mm
cases showed increased expression of pro-survival genes and
decreased expression of apoptotic genes.
From our Annexin-V assay results, a remarkable increase in
apoptosis was observed. The mechanism of apoptotic induction
might be due the up-regulation of pro-apoptotic gene BAX (Bcl-2
associated X), PDCD7 (Programmed cell death protein), TRAF6
(Tumor necrosis factor receptor-associated factor 6) and DFFB
(DNA fragmentation factor subunit beta) upon Tiam1 knockdown
[50,51,52,53,54]. Similar to our results, apoptotic cell death has
been observed earlier upon Tiam1 silencing [55].
Since endogenous Tiam1 is localized in both plasma membrane
and cytoplasm, we were interested to find out which domain of the
Tiam1 protein regulates the localization intracellularly in RB cells.
We elucidated that N-terminal PH domain of Tiam1 mediates the
membrane localization and invasion but not the C-terminal PH
domain and targeting the N-terminal PH domain of Tiam1 affects
the cell migration and invasion. Earlier studies showed that
localization of Tiam1 to plasma membrane requires N-terminal
PH domain. Also the membrane localization of Tiam1 is required
for the activation of the c-Jun NH2-terminal kinase (JNK) thus
leading to successful Rac mediated signaling [13]. N-terminal PH
domain of Tiam1 has affinity towards phosphoinositides and its
interaction with transmembrane domain accelerates the mem-
brane localization. For the first time our data has additionally
elucidated the importance of the N-terminal region with respect to
the migration as it is directly correlating with actin cytoskeleton
modulation in RB. From our findings, we suggest that Tiam1 can
be utilized as a potential target for RB therapy. In future, docking
studies to find potent inhibitors to RBD binding or alternatively
aptamers targeting the N-terminal PH domain of Tiam1 need to
be isolated, which have better application in vivo for drug delivery
purposes.
Supporting Information
Figure S1 Pathways and gene ontology altered by
Tiam1. A. Pie chart represents significantly de-regulated
pathways in response to Tiam1 silencing. B. Graphical represen-
tation of significantly de-regulated gene ontology.
(TIF)
Table S1 Deregulated genes in Tiam1 silenced Y79
cells. List of genes shortlisted and used for Hierarchial clustering
and further pathway and gene ontology analysis.
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